Abstract
Soft-tissue sarcomas are rare tumours of extreme heterogeneity. The degree of malignancy, the dimensions, the spontaneous necrosis and vascular invasion are important prognostic factors. Surgery, curative in more than 90 % of cases, is the main therapy. Obtaining adequate surgical margins (wide or radical) is essential. An important surgical aggressiveness however requires more complex reconstructions (free flaps, motor units transplants, nerves and tendons grafts etc.). Resection margins are must be adequate or if not, the use of radiotherapy will improve local control. The effect of radiotherapy does not differ significantly whether it is used pre- or post-operatively. The first, however, most frequently leads to local complications. Interstitial brachytherapy and intra-operative radiotherapy have special advantages. Currently, with surgery combined with radiation therapy, the risk of local recurrence is less than 10 %. Loco-regional treatment (infusion of hyperthermia with TNF, neo-adjuvant chemotherapy, etc.) are reserved for non-operable patients and may produce a reduction in the neoplastic mass which allows conservative surgery in 85 % of cases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abbatucci JS, Mandard AM, Bouliee N, Vernhes JC, Lozier JC (1990) End results in 130 cases of soft tissue sarcomas of the limbs and trunk walls treated by a systematic radio-surgical association. Multivariate analysis of prognostic factors. Chir Organi Mov 75(1):146–149
Alekhteyar KM, Leung DM, Brennan MF, Harrison LB (1996) The effect of combined external bean radiotherapy and brachytherapy on local control and wound complications in patients with positive microscopic margin. Int J Radiat Oncol Biol Phys 36(2):321–324
Badelino F, Canavese G, Palumbo R, Vecchio C, Catturich A, Grimaldi A, Raffo P, Villani G, Di Somma C, Gipponi M, Tomei D, Rosato F, Toma S (1997) Surgery after concomitant radio-chemio therapy treatment in advanced soft tissue sarcomas (STS); feasibility and activity of a multimodality limb sparing protocol. In: International Society of limb salvage, IXth symposium. New York
Beltrami G, Rüdiger HA, Mela MM et al (2008) Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas. Eur J Surg Oncol 34:811–816
Bujko K, Suit MD, Springfield DS, Convery K (1993) Wound healing after preoperative radiation for sarcomas of tissue. Surg Gynecol Obstet 176:124
Cheng EY, Dusenbery KE, Winters MR, Thompson RC (1996) Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol 61(2):90–99
Choong PFM, Pritchard DJ, Rock MG, Sim FH, Frassica FJ (1995) Survival after pulmonary metastatectomy in soft tissue sarcoma: prognostic factors in 214 patients. Acta Orthop Scand 66(6):561–568
Choong PFM, Gstafson P, Rydholm A (1995) Size and timing of local recurrence predicts metastases in soft tissue sarcoma. Growth rate index retrospectively analyzed in 134 cases. Acta Orthop Scand 66(2):147–152
Choong PFM, Gustafson P, Willelm M (1995) Prognosis following locally recurrent soft tissue sarcoma. A staging system based on primary and recurrent tumor characteristics. Int J Cancer 60:33–37
Di Filippo F, Lise M, Rossi CR, Vaglini M, Azzarelli A, Anzà M, Santinami M, Cavaliere F, Giannarelli D, Schiratti M, Vecchiato A, Psailor A, Quagliolo V, Cavaliere R (1997) Hyperthemic autoblastic perfusion with a TNF and dexorubicina for the treatment of soft tissue limb sarcoma in candidates for amputation: results of I study. Proc Am Soc Clin Oncol 16:501–1800
Eggermont AM, Schraffordt Koeps M, Lienard D, Kroon BB, Van Geel AM, Hoekstre MJ, Lejeune FJ (1994) Isolated limb perfusion with high dose tumor necrosis factor alpha in combination with interferon – gamma and melphalan for non resectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 14(10):2653–2665
Eilber FR, Eckandt JJ, Rosen G, Fu YS, Seeger LL, Selch MT (1993) Neoadjuvant chemotherapy and radiotherapy in the multidisciplinary management of soft tissue sarcomas of the extremity. Surg Oncol Clin North Am 2(4):611–620
Eilber FR, Eckandt JJ, Rosen G, Selch M, Fu YS (1995) Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am 9(4):418–423
Engellau J, Bendahl P-O, Persson A et al (2005) Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumour sections and tissue microarrays. Hum Pathol 36:994–1002
Frustaci S, Gherlinzoni F, De Paoli A, Pignatti G, Zmerly M, Azzarelli A, Comandone A, Buonadonna A, Olmi P, Ippolito V, Barbieri E, Apice G, Zakotmic B, Bacci G, Picci P (1997) Preliminary results o fan adjuvant randomized trial on high risk extremity soft tissue sarcomas. Proc Am Soc Clin Oncol 16:468–1785
Goodland JR, Fletcher CD, Smith MA (1996) Surgical resection of primary soft tissue – sarcoma- incidence of residual tumor in 95 patients needing re – excision after local resection. J Bone Join Surg Br 78(4):658–661
Grunhagen DJ, de Wilt JHW, Graveland WJ et al (2006) Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumour necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 106:1776–1784
Gustafson P, Akerman M, Alvegard TA et al (2003) Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis – the SIN-system. Eur J Cancer 39:1568–1576
Gustafson P (1994) Soft tissue sarcoma, epidemiology and prognosis in 508 patients. Acta Orthop Scand 65(Suppl 259):2–31
Habrand JL, Gerbaulet A, Pejonic MH (1991) Twenty years experience of interstitial iridium brachytherapy in the management of soft tissue sarcomas. Int J Radiat Oncol Biol Phys 20:405–411
Kawaguehi N, Matumoto S, Manabe J (1995) New method of evaluating the surgical margin and safety margin for muscolo-skeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121:555–563
Lack E, Steinberg SM, White DE, Kimsellon T, Glatstein E, Chang AE, Rosenberg SA (1989) Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol 41:263–273
Lawis JJ, Leung D, Woodruff JM, Breunan MF (1997) Extremity soft tissue sarcoma: are two operations better than one? In: International Society of Limb Salvage. IXth international symposium. New York
Mandard AM, Petiot JF, Marnay J, Mandard JC, Hassle J, De Ranieri E, Dupin P, Merlin P, De Ranieri J, Tangery A, Boulier M, Abbatucci JS (1989) Prognostic factors in soft tissue sarcomas. Cancer 63:1437–1451
Mankin HJ, Mankin CJ, Simon MA (1996) The hazards of the biopsy revisited. J Bone Joint Surg Am 78(5):656–663
Meller I, Gutman M, Schlush L, Abu Abid E, Kolender Y, Merimsky O, Imber M, Isakov J, Klausner JM (1997) Hyperthermic isolated limb perfusion with high dose necrosis factor alpha and melphalan as a limb preserving modality in patients with extensive soft tissue sarcomas. In: International Society of Limb Salvage, transaction IXth symposium, New York
Mintzer DM, King JJ, Alavi A et al (2007) Utility of PET scan in predicting chemotherapeutic response in soft tissue sarcoma patients. ASCO annual meeting proceedings part I. J Clin Oncol 25(18S, June 20 supplement):10021
Muhic A, Hovgaard D, Petersen MM et al (2008) Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation. Radiother Oncol 88:382–387
Noria S, Davis A, Kandel R, Levesque J, O’Sullivan B, Wunder J, Bell R (1996) Residual disease following unplanned excision of soft tissue sarcoma of an extremity. J Bone Joint Surg Am 78(5):650–655
Pisters PW, Harrison LB, Leung DII, Woodruff JM, Casper ES, Brennan MF (1996) Long term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14(3):859–868
Pisters PWT, O’Sallivan B, Maki RG (2007) Evidence based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 25:1003–1008
Pisters PWT, Patel SR, Varma DGK, Evans HL, Respondek PM, Chen MP, Nguyen HTB, Feig BW, Hunt K, Pollack A, Zagons G, Pollock RE, Benjamin RS (1997) Pathologic complete response following preoperative multimodality therapy for stage IIIB extremity soft tissue sarcoma. Proc Am Soc Clin Oncol 16:499–1795
Rydholm A (1997) Prognostic factor in soft tissue sarcoma. Acta Orthop Scand 68(Suppl 273):148–155
Rydholm A (1997) Surgery without radiotherapy in soft tissue sarcoma. Acta Orthop Scand 273(68):117–119
Schwarzbach MH, Hormann Y, Hinz U et al (2005) Results of limb-sparing surgery with vascular replacement for soft tissue sarcoma in the lower extremity. J Vasc Surg 42:88–97
Sim FII, Frassica FJ, Frassica DA (1994) Soft tissue tumors, diagnosis evaluation and management. J Am Acad Orthop Surg 2(4):202–211
Stotter AT, A’Hern RP, Fischer C, Mott AF, Fallowfield ME, Westbury G (1990) The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 65:1119–1129
Sugiura H, Takahashi M, Katagiri H et al (2002) Additional wide resection of malignant soft tissue tumours. Clin Orthop 394:201–210
Suit HD (1989) The George Edelstym memorial lecture. Radiation in the management of malignant soft issue tumors. Clin Oncol 1:5–10
Szendroi M, Zoltan S, Kinga K, Zsuzsa P (2010) Diagnosis and treatment of soft tissue sarcoma. In: Bentley G (ed) European instructional course lectures. 11th EFORT Congress, Madrid, pp 37–49
Tepper JE, Smit HD (1985) Radiation therapy alone for sarcoma of soft tissue. Cancer 56:475–479
Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MK (1995) Adjuvant chemotherapy for soft tissue sarcoma; review and meta-analysis of the published result of randomized clinical trials. Br J Cancer 72(2):469–475
Van Geel AN, Egermont MM, Hanssens PEJ et al (2003) Factors influencing prognosis after initial inadequate excision (IIE) for soft tissue sarcoma. Sarcoma 7:159–165
Van Giunkel RJ, Hoekstra MJ, Pruim J, Nieweg OE, Molenaar WM, Paans AM, Willemsen AT, Vallburg W, Koops IIS (1996) FDG RET too evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 37(6):984–990
Vraa S, Keller J, Nielsen OS et al (2001) Soft tissue sarcoma of the thigh. Surgical margin influences local recurrence but not survival in 152 patients. Acta Orthop Scand 72:72–77
Willet CG, Suit MD, Tepper JE (1991) Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer 68:278–283
Zagara GK, Ballo MT, Pisters PW et al (2003) Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer 97:2544–2553
Zormig C, Peiper M, Schroder S (1995) Reexcision of soft tissue sarcoma after inadequate initial operation. Br J Surg 82(2):278–279
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 EFORT
About this chapter
Cite this chapter
Capanna, R., Frenos, F. (2013). Surgery for Soft Tissue Sarcomas. In: Bentley, G. (eds) European Instructional Lectures. European Instructional Lectures, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36149-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-36149-4_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36148-7
Online ISBN: 978-3-642-36149-4
eBook Packages: MedicineMedicine (R0)